Measuring what matters
Real-time impact.
We measure our success by the patients reached, medicines delivered, and communities served. Updated monthly.
By the numbers
Key Statistics
10,000+
Consultations (Target)
Goal since program launch in 2026
7
Countries by 2030
Currently active in Togo, expanding to Ghana and Benin
14
Languages (Planned)
Including Ewe, Hausa, Yoruba, Twi, Moore, Bambara
500+
Partner Clinics (Target)
Licensed clinics and pharmacy network
12,000+
Medicines (Target)
WHO-prequalified essential medicines
3,200+
Families (Target)
With ongoing care relationships
Where we work and where we are going
Country Expansion Roadmap
Togo is our only active country of operations. All other countries are upcoming targets on our 2030 expansion roadmap.
Active: primary country of operations, launched 2026
Upcoming: conversations with Ghana Health Service underway
Upcoming: outreach to Ministry of Health in progress
Upcoming: urban and semi-rural outreach planned
Upcoming: refugee population focus
Upcoming: 2028 expansion roadmap
Upcoming: 2029 expansion roadmap
Clinical breakdown
Disease Categories
What this tells us
Malaria and fever account for the largest share of consultations, consistent with West Africa's disease burden. Respiratory illnesses, particularly in younger children and dry-season months, represent the second largest category.
Maternal health consultations are growing as word of our services reaches pregnant women and new mothers in underserved communities.
Data Transparency
Data updated monthly. Individual patient data is fully anonymized. See our Data Privacy statement.
2026 Annual Report
Full program data, financial summary, and year-in-review for our inaugural year of operations.